PRF Technologies (PRFX) Receivables (2019 - 2025)
PRF Technologies (PRFX) posted quarterly Receivables of $142000.0 for Q4 2025, up 19.33% year-on-year from $119000.0 in Q4 2024, and down 45.8% on a QoQ basis from $262000.0 in Q2 2025.
PRF Technologies (PRFX) Receivables (2019 - 2025) Analysis & Trends
PRF Technologies (PRFX) has reported Receivables for 7 consecutive years, with $142000.0 the latest figure, recorded in Q4 2025.
- Quarterly Receivables rose 19.33% year-over-year to $142000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $142000.0 (up 19.33% YoY) and the FY2025 annual result came in at $142000.0, up 19.33% from the prior year.
- Receivables eased to $142000.0 in Q4 2025 per PRFX's latest filing, from $262000.0 in the prior quarter.
- Over the last five years, Receivables for PRFX reached as high as $262000.0 in Q2 2025 and fell as low as $45000.0 in Q4 2023.
- A 5-year average of $140166.7 and a median of $130500.0 in 2024 frame the typical range for Receivables.
- Annual changes were most pronounced in 2021 — Receivables soared 311.32% — and 2022, when it tumbled 74.77%.
- Year by year, Receivables stood at $218000.0 in 2021, then plunged by 74.77% to $55000.0 in 2022, then retreated by 18.18% to $45000.0 in 2023, then jumped by 164.44% to $119000.0 in 2024, then rose by 19.33% to $142000.0 in 2025.
- According to Business Quant data, Receivables over the past three periods registered $142000.0, $262000.0, and $119000.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 2.99 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.51 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 6.46 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 312.00 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 15.29 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 3.58 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 768.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.15 Bn |
| 10 | PRF Technologies | 745,168.93 | 451,168.93 | - | 142,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 142,000.00 |
| Jun 30, 2025 | 262,000.00 |
| Dec 31, 2024 | 119,000.00 |
| Dec 31, 2023 | 45,000.00 |
| Dec 31, 2022 | 55,000.00 |
| Dec 31, 2021 | 218,000.00 |
| Dec 31, 2020 | 53,000.00 |
| Dec 31, 2019 | 22,000.00 |